Clear Search sequence regions


  • APOBEC3A (1)
  • asian (2)
  • BRCA1 (9)
  • BRCA2 (1)
  • cell (3)
  • dna (1)
  • free (2)
  • humans (1)
  • kaplan meier estimate (1)
  • parallel (1)
  • patients (5)
  • protein human (1)
  • rich (4)
  • romania (1)
  • TILs (3)
  • TP53 (1)
  • Sizes of these terms reflect their relevance to your search.

    Genomic patterns of nasopharyngeal carcinomas (NPCs) have as yet been studied in Southeast Asian (SEA) patients. Here, we investigated genomic patterns of locally advanced NPC Southeast European (SEE) patients treated with chemoradiotherapy. We examined 126 tumors (89% EBV positive) from Greek and Romanian NPC patients with massively parallel sequencing. Paired tumor-cell-rich (TC) and infiltrating-lymphocyte-rich (TILs) samples were available in 19 and paired tumor-germline samples in 68 cases. Top mutated genes were BRCA1 (54% of all tumors); BRCA2 (29%); TP53 (22%); KRAS (18%). Based on the presence and number of mutations and mutated genes, NPC were classified as stable (no mutations, n = 27); unstable (>7 genes with multiple mutations, all BRCA1 positive, n = 21); and of intermediate stability (1-7 singly mutated genes, n = 78). BRCA1 p.Q563* was present in 59 tumors (48%), more frequently from Romanian patients (p < 0.001). No pathogenic germline mutations were identified. NPC exhibited APOBEC3A/B and nucleotide-excision-repair-related mutational signatures. As compared to TC, TILs demonstrated few shared and a higher number of low frequency private mutations (p < 0.001). In multivariate analysis models for progression-free survival, EBV positivity was a favorable prognosticator in stable tumors; BRCA1 mutations were unfavorable only in tumors of intermediate stability. In conclusion, other than described for SEA NPC, somatic BRCA1 mutations were common in SEE NPC; these were shared between TC and TILs, and appeared to affect patient outcome according to tumor genomic stability status. Along with the identified mutational signatures, these novel data may be helpful for designing new treatments for locally advanced NPC. © 2017 UICC.

    Citation

    George Fountzilas, Amanda Psyrri, Eleni Giannoulatou, Ioannis Tikas, Kyriaki Manousou, Dimitra Rontogianni, Elisabeta Ciuleanu, Tudor Ciuleanu, Liliana Resiga, Thomas Zaramboukas, Kyriaki Papadopoulou, Mattheos Bobos, Sofia Chrisafi, Eleftheria Tsolaki, Konstantinos Markou, Evangelos Giotakis, Angelos Koutras, Elsa Psoma, Anna Kalogera-Fountzila, Maria Skondra, Christina Bamia, Dimitrios Pectasides, Vassiliki Kotoula. Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe. International journal of cancer. 2018 Jan 01;142(1):66-80

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28857155

    View Full Text